We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Roche Logo

Roche

Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in vitro diagnostics and a global supplier of transformative, innovative solutions across major disease areas. They are a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Latest Roche Content

Tackling Cancer by Stabilizing Chromosomes content piece image
News

Tackling Cancer by Stabilizing Chromosomes

Researchers have discovered that the enzyme Dicer, which is found in mammalian cells, plays a key part in the structural integrity of the genome.
Implementing Cellular Rejuvenation Therapy Reverses Signs of Aging in Mice content piece image
News

Implementing Cellular Rejuvenation Therapy Reverses Signs of Aging in Mice

A combination of four reprogramming molecules that reset the epigenetic marks of older mice has been shown to reverse signs of aging with no side effects over time.
Element Biosciences Launches the AVITITM System To Democratize Access to Genomics content piece image
Product News

Element Biosciences Launches the AVITITM System To Democratize Access to Genomics

Element Biosciences Inc. has announced the commercial launch of the Element AVITI™ System, a benchtop sequencer offering an unrivaled combination of performance, cost and flexibility.
Designing in Sustainability in Science content piece image
Industry Insight

Designing in Sustainability in Science

With a reliance on single-use plastics, significant waste and high energy usage, the carbon footprint of the biopharma industry is large. If we are to accelerate the path to net zero, it is therefore critical to ensure sustainability in science.
Uncovering Real-World Patient Insights With Social Media and NLP content piece image
Industry Insight

Uncovering Real-World Patient Insights With Social Media and NLP

Historically, drug researchers have relied on methods such as focus groups and questionnaires for first-person accounts of patient-reported outcomes. Social media has emerged as a lower cost alternative that is increasingly accepted as a reputable source of information by the research community.
Omicron Resistant to Most Monoclonal Antibodies, but Neutralized by Booster content piece image
News

Omicron Resistant to Most Monoclonal Antibodies, but Neutralized by Booster

Scientists studied the sensitivity of the Omicron variant to monoclonal antibodies used in clinical practice to prevent severe forms of the disease in people at risk, as well as to antibodies in the blood of individuals previously infected with SARS-CoV-2 or vaccinated.
Advertisement